FDA

A changing research environment means regulators and institutional review boards must adapt.

Lawyers and regulators are concerned about the lack of regulations for the use of robotic technology in surgeries.

FDA warns consumers that the agency has not evaluated most CBD products and cannot say they are safe.

Unlike new drugs and devices, combination products may fall through the regulatory cracks.

Congress should adopt stronger restrictions on former federal officials’ ability to lobby their old employers.

Scholar argues that FDA can, and should, regulate marijuana edibles.

FDA ought to promote stem cell therapy by easing up on regulation and its aggressive enforcement.

The Trump Administration plans to eliminate flavored vaping products from the market.

Scholar says that human milk should be regulated to ensure donor milk is safe, accessible, and affordable.

Scholars argue that federal agencies should not use guidance documents to regulate controversial issues.

Better oversight is needed of the “biohacking” that individuals perform on themselves.

A recent FDA proposed rule would transform over-the-counter sunscreen regulation.